Atlas Trials

SQ Innovation, Inc.

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SQ Innovation, Inc.

RecordFirmDate
Study to Compare Bioavailability and Pharmacokinetics of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80 mg) Administered Intravenously in Healthy Volunteers (NCT07269496)SQ Innovation, Inc.2026-02-09
A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers (NCT05296083)SQ Innovation, Inc.2022-03-17
A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure (NCT04846816)SQ Innovation, Inc.2021-05-06
An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device) (NCT04836572)SQ Innovation, Inc.2021-01-20
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure (NCT04384653)SQ Innovation, Inc.2020-10-17

Track SQ Innovation, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.